Czechia· CZ-0272979
PYLERA
A bismuth subcitrate, tetracycline and metronidazole product containing bismuth subcitrate potassium monohydrate + metronidazole + tetracycline hydrochloride, registered in Czechia by Laboratoires Juvisé Pharmaceuticals, Villeurbanne. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Bismuth subcitrate, tetracycline and metronidazole is registered in 9 of 19 countries.
Countries holding a registration under ATC A02BD08 (bismuth subcitrate, tetracycline and metronidazole), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Bismuth subcitrate, tetracycline and metronidazole · ATC A02BD08
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- BISMUTH SUBCITRATE POTASSIUM MONOHYDRATE + METRONIDAZOLE + TETRACYCLINE HYDROCHLORIDE
- Manufacturer
- Laboratoires Juvisé Pharmaceuticals, Villeurbanne
- Country
- Czechia (CZ)
- ATC code
- A02BD08
- ATC class
- Bismuth subcitrate, tetracycline and metronidazole
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl0272979120CZK 1517.69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bismuth subcitrate, tetracycline and metronidazole in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandPyleraInPharm Sp. z o.o.
- United StatesBismuth Subcitrate Potassium, Metronidazole and Tetracycline HydrochlorideH2-Pharma, LLC
- GermanyPyleraLaboratoires Juvise Pharmaceuticals
- SwitzerlandPylera 140 mg/125 mg/125 mg, HartkapselnMedius AG
- IrelandPylera 140 mg/125 mg/125 mg capsules, hardLaboratoires Juvise Pharmaceuticals
- SwedenPylera 140 mg/125 mg/125 mg Kapsel, hårdLaboratoires Juvise Pharmaceuticals
- FrancePYLERA 140 mg/125 mg/125 mg, géluleLABORATOIRES JUVISE PHARMACEUTICALS
- SpainPYLERA 140 mg/125 mg/125 mg CAPSULASLaboratoires Juvise Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Pylera
- Belgium · Tryplera
- Bulgaria · Pylera
- Germany · Pylera
- Denmark · Pylera
- Estonia · Pylera
- Spain · Pylera
- Finland · Pylera
- France · Pylera
- United Kingdom (Northern Ireland) · Pylera
- Ireland · Pylera
- Italy · Pylera
- Lithuania · Pylera
- Luxembourg · Tryplera
- Latvia · Pylera
- Malta · Pylera
- Norway · Pylera
- Poland · Pylera
- Portugal · Pylera
- Romania · Pylera
- Sweden · Pylera
- Slovakia · Pylera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c3a29b4-66b3-4ec2-bcc3-4953270b7adf GET /v1/drugs/8c3a29b4-66b3-4ec2-bcc3-4953270b7adf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": "140MG/125MG/125MG",
"pack_size": "120",
"substance": "BISMUTH SUBCITRATE POTASSIUM MONOHYDRATE + METRONIDAZOLE + TETRACYCLINE HYDROCHLORIDE",
"cz_kod_sukl": "0272979",
"product_type": "CH",
"substance_codes": "20451,943,1436",
"registration_state": "R",
"registration_number": "09/248/14-C"
}See everything about bismuth subcitrate, tetracycline and metronidazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.